OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Pharming Group NV PHARMING GROUP .../  NL0010391025  /

London International
2024-05-02  4:52:46 PM Chg. +0.0115 Volume Bid5:40:07 PM Ask5:40:07 PM High Low
0.8925EUR +1.31% 103,178
Turnover: 3,055.3215		 -Bid Size: - -Ask Size: - 0.8925 0.8805
GlobeNewswire 04-24 Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 20...
GlobeNewswire 04-08 Pharming announces completion of enrollment in pediatric clinical trial of leniolisib
GlobeNewswire 04-03 Pharming Group to participate in April investor conferences
GlobeNewswire 03-25 Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the ...
GlobeNewswire 03-14 Pharming Group reports fourth quarter and full year 2023 financial results
GlobeNewswire 02-29 Pharming Group to report fourth quarter and full year 2023 financial results on March 14
GlobeNewswire 02-08 Pharming Group to participate in February investor conferences
GlobeNewswire 01-08 Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update
GlobeNewswire 2023-12-13 Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies ...
GlobeNewswire 2023-11-21 Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years fo...
GlobeNewswire 2023-11-13 Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Acc...
GlobeNewswire 2023-11-01 Pharming Group to participate in November investor conferences
GlobeNewswire 2023-10-26 Pharming Group reports third quarter 2023 financial results
GlobeNewswire 2023-10-12 Pharming Group to report third quarter 2023 financial results on October 26
GlobeNewswire 2023-09-25 Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders
GlobeNewswire 2022-01-10 Orchard Therapeutics Announces Recent Commercial and Regulatory Progress for Late-stage HSC Gene The...
GlobeNewswire 2021-11-04 Orchard Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Business Upd...
GlobeNewswire 2021-08-04 Orchard Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Business Up...
GlobeNewswire 2021-07-29 Oncorus Expands its Board with Appointment of Barbara Yanni
GlobeNewswire 2021-07-01 Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo ...
GlobeNewswire 2021-01-20 Longboard Pharmaceuticals Appoints Phillip Schneider and Paul Sekhri to Board of Directors
GlobeNewswire 2020-10-13 iBio Announces Financial Results for Fiscal Year Ended June 30, 2020
GlobeNewswire 2020-02-03 iBio and CC-Pharming Initiate Joint Development of Coronavirus Vaccine
GlobeNewswire 2019-12-16 iBio Reports Progress on its Bio-Better Rituximab Collaboration with CC-Pharming
GlobeNewswire 2019-08-26 iBio and CC-Pharming Expand Business Collaboration in China